|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
价值评估 |
盈利(现时/预测)
-2.13/0.64
|
企业价值
460.82M
|
资产负债 |
每股账面净值
1.31
|
现金流量 |
现金流量率
--
|
损益表 |
收益
27.46M
|
每股收益
0.31
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟:2025/01/11 18:06 EST
同行比较之报价最少15分钟延迟
业务概览
|
|||
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With unique, data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community. |